| Comparison of placebo and bromocriptine in the treatment of patients with normoprolactinaemic amenorrhoea. | |
| | |
MedLine Citation:
|
PMID: 361068 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Fourteen women with normoprolactinaemic amenorrhoea were treated with bromocriptine (2.5 mg twice daily) for a period ranging from 4 to 17 weeks, while a matched group fo 19 amenorrhoeic women were treated with a placebo (one tablet twice daily) for 4 to 12 weeks. About half of the patients in both groups had at least one episode of vaginal bleeding during treatment. There was no clear difference in the menstrual and ovulatory pattern between placebo and bromocriptine groups. |
| | |
Authors:
|
P G Crosignani; E Reschini; G C Lombroso; M Arosio; M Peracchi |
Related Documents
:
|
21272508 - Addressing adverse effects of antipsychotic treatment in young patients with schizophre... 21515398 - Impact of beta-glucan on the faecal microbiota of polypectomized patients: a pilot study. 21532348 - Update on the role of palliative oxygen. 7899538 - A randomized, placebo-controlled, crossover trial of danazol for the treatment of preme... 17241408 - Botulinum toxin type a treatment of multiple upper facial sites: patient-reported outco... 20636718 - The urico-ictus study, a phase 3 study of combined treatment with uric acid and rtpa ad... |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article |
Journal Detail:
|
Title: British journal of obstetrics and gynaecology Volume: 85 ISSN: 0306-5456 ISO Abbreviation: Br J Obstet Gynaecol Publication Date: 1978 Oct |
Date Detail:
|
Created Date: 1979-01-26 Completed Date: 1979-01-26 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7503752 Medline TA: Br J Obstet Gynaecol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 773-5 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Amenorrhea
/
drug therapy* Bromocriptine / therapeutic use* Clinical Trials as Topic Female Humans Placebos Progesterone / blood Prolactin / blood |
| Chemical | |
Reg. No./Substance:
|
0/Placebos; 25614-03-3/Bromocriptine; 57-83-0/Progesterone; 9002-62-4/Prolactin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A comparison of salbutamol and ethanol in the treatment of preterm labour.
Next Document: Group B beta haemolytic streptococci in the female genital tract: a study of four clinic populations...